S&P 500
(0.12%) 5 303.27 points
Dow Jones
(0.34%) 40 004 points
Nasdaq
(-0.07%) 16 686 points
Oil
(-0.05%) $80.02
Gas
(1.68%) $2.67
Gold
(1.04%) $2 442.50
Silver
(4.24%) $32.59
Platinum
(1.33%) $1 104.50
USD/EUR
(-0.06%) $0.919
USD/NOK
(-0.07%) $10.67
USD/GBP
(0.00%) $0.787
USD/RUB
(-0.03%) $90.94

Realtime updates for Hyundai Bioscience Co., [048410.KQ]

Exchange: KOSDAQ
Last Updated19 May 2024 @ 23:35

-0.95% KRW 20 900

Live Chart Being Loaded With Signals

Commentary (19 May 2024 @ 23:35):

Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body...

Stats
Today's Volume 164 394
Average Volume 426 307
Market Cap 832.20B
EPS KRW0 ( 2024-05-15 )
Next earnings date ( KRW0 ) 2024-08-08
Last Dividend KRW0 ( N/A )
Next Dividend KRW0 ( N/A )
P/E 0
ATR14 KRW55.70 (0.27%)

Volume Correlation

Long: 0.13 (neutral)
Short: -0.41 (neutral)
Signal:(49.862) Neutral

Hyundai Bioscience Co., Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hyundai Bioscience Co., Correlation - Currency/Commodity

The country flag -0.37
( neutral )
The country flag -0.55
( weak negative )
The country flag 0.28
( neutral )
The country flag -0.55
( weak negative )
The country flag 0.21
( neutral )
The country flag -0.16
( neutral )

Hyundai Bioscience Co., Financials

Annual 2023
Revenue: KRW9.48B
Gross Profit: KRW3.92B (41.36 %)
EPS: KRW-364.53
FY 2023
Revenue: KRW9.48B
Gross Profit: KRW3.92B (41.36 %)
EPS: KRW-364.53
FY 2022
Revenue: KRW7.85B
Gross Profit: KRW1.95B (24.79 %)
EPS: KRW-401.53

Financial Reports:

No articles found.

Hyundai Bioscience Co., Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Hyundai Bioscience Co.,

Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body. The company provides Vitabrid C12, a new-conceptual vitamin C product that delivers active vitamin C into the skin. It also develops organic-inorganic hybrid technology, a drug delivery system technology that allows the selective and effective delivery of active substances on the target area in combination with bio-friendly minerals, as well as in anticancer drug carrier technology. The company was founded in 2000 and is based in Seoul, South Korea.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators